HealthMore in Health →
FDA Search for New Biologics and Vaccines Chief Signals Another Key Leadership Shift
The FDA is moving closer to naming a new leader for its Center for Biologics Evaluation and Research, according to Endpoints News, a decision with implications for vaccines and biologic regulation.
Key Takeaways
- Endpoints reports the FDA is nearing a decision on a new CBER director.
- The search follows the controversial tenure of outgoing leader Vinay Prasad.
DE
DT Editorial AI··via endpoints.news